Literature DB >> 9415110

Twenty-four hour growth hormone secretion in a patient with Werner's syndrome.

C D Rubin1, B Reed.   

Abstract

OBJECTIVE: To assess the 24-h endogenous secretory growth hormone (GH) profile and serum insulin-like growth factor-I (IGF-I) response to exogenous recombinant human growth hormone (rhGH) in a patient with Werner's syndrome.
DESIGN: Blood sampling every 20 min for 24 h followed by three daily injections of growth hormone.
SETTING: General Clinical Research Center. PATIENTS: Single patient with Werner's syndrome. MEASUREMENTS: Serum GH and IGF-I.
RESULTS: Growth hormone pulses were absent during the 24-h monitoring period. Likewise, integrated GH concentrations were very low at 0.25 mu min/mL, and no peaks occurred after sleep onset. Following single daily administration of rhGH, serum GH and IGF-I rose.
CONCLUSIONS: Our findings support previous but less extensive studies suggesting patients with Werner's syndrome have reduced growth hormone levels. Preliminary investigations using rhGH in patients with Werner's syndrome should be considered.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9415110     DOI: 10.1016/0531-5565(96)00031-9

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  3 in total

1.  Antioxidative mechanisms and plasma growth hormone levels: potential relationship in the aging process.

Authors:  H M Brown-Borg; A M Bode; A Bartke
Journal:  Endocrine       Date:  1999-08       Impact factor: 3.633

Review 2.  Tissue-specific accelerated aging in nucleotide excision repair deficiency.

Authors:  Laura J Niedernhofer
Journal:  Mech Ageing Dev       Date:  2008-05-01       Impact factor: 5.432

Review 3.  Growth hormone and aging.

Authors:  A Bartke
Journal:  Endocrine       Date:  1998-04       Impact factor: 3.925

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.